Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,011 public trials 1,221 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors

NCT00427349

Conditions
Adenocarcinoma, Adenoma, Adenoma, Islet Cell, +25 more
Locations
  • Hematology Oncology Associates of Illinois - Berwyn Berwyn, Illinois, United States
  • Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States
  • Hematology and Oncology Associates Chicago, Illinois, United States
  • Midwest Center for Hematology/Oncology Joliet, Illinois, United States
View all 112 locations
View Trial Details
Completed

Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer

NCT02267603

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +18 more
Locations
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 13 locations
View Trial Details
Completed

Low Dose Radiation Therapy for Glioblastoma Multiforme

NCT01466686

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States
  • Suburban Hospital Bethesda, Maryland, United States
View Trial Details
Completed

Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery

NCT00700882

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Stanford Cancer Center Stanford, California, United States
  • Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital Fort Lauderdale, Florida, United States
  • Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States
View all 153 locations
View Trial Details
Completed

PEG-Interferon Alfa-2b in Treating Patients With Stage IV Melanoma

NCT00049530

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Lakeland Regional Cancer Center at Lakeland Regional Medical Center Lakeland, Florida, United States
  • St. Joseph Medical Center Bloomington, Illinois, United States
  • Graham Hospital Canton, Illinois, United States
View all 32 locations
View Trial Details
Completed

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

NCT00071981

Conditions
Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations
  • Veterans Affairs Medical Center - Palo Alto Palo Alto, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States
  • CCOP - Christiana Care Health Services Newark, Delaware, United States
View all 65 locations
View Trial Details

Related conditions